{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:37Z","timestamp":1786120417552,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Shanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["202503021211128"],"award-info":[{"award-number":["202503021211128"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004480","name":"Shanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["202203021222259"],"award-info":[{"award-number":["202203021222259"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["CPOF202301"],"award-info":[{"award-number":["CPOF202301"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","award":["20230022"],"award-info":[{"award-number":["20230022"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020758","name":"Science and Technology Innovation Group of Shanxi Province","doi-asserted-by":"publisher","award":["202204051002030"],"award-info":[{"award-number":["202204051002030"]}],"id":[{"id":"10.13039\/501100020758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300641"],"award-info":[{"award-number":["32300641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioadv.2026.215044","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:48:03Z","timestamp":1782456483000},"page":"215044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A multifunctional graphene oxide-based nanoplatform sensitizes ovarian cancer to cisplatin via ROS-PINK1\/Parkin mitophagy under chemo-photothermal-photodynamic synergy"],"prefix":"10.1016","volume":"188","author":[{"given":"Xiaoning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingmei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioadv.2026.215044_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215044_bb0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","article-title":"Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance: a narrative review","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMA Oncol."},{"issue":"15","key":"10.1016\/j.bioadv.2026.215044_bb0015","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40265-023-01934-0","article-title":"Treatment of ovarian Cancer beyond PARP inhibition: current and future options","volume":"83","author":"Garg","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.bioadv.2026.215044_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104434","article-title":"Clinical and molecular features of platinum resistance in ovarian cancer","volume":"201","author":"Miras","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioadv.2026.215044_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcancer.2021.08.005","article-title":"Platinum-resistant ovarian cancer: from drug resistance mechanisms to liquid biopsy-based biomarkers for disease management","volume":"77","author":"Khan","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"26","key":"10.1016\/j.bioadv.2026.215044_bb0030","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1039\/D1TB00753J","article-title":"Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance","volume":"9","author":"Xie","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"17","key":"10.1016\/j.bioadv.2026.215044_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176280","article-title":"Functionalized graphene oxide for chemotherapeutic drug delivery and cancer treatment: a promising material in nanomedicine","volume":"21","author":"Sharma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215044_bb0040","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/acsami.6b11209","article-title":"Mesoporous silica coated Polydopamine functionalized reduced graphene oxide for synergistic targeted chemo-Photothermal therapy","volume":"9","author":"Shao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215044_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092286","article-title":"Graphene-based nanomaterials for photothermal therapy in cancer treatment","volume":"15","author":"B\u00e1ez","year":"2023","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/j.bioadv.2026.215044_bb0055","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1002\/anie.201911477","article-title":"Two-dimensional nanomaterials for Photothermal therapy","volume":"59","author":"Liu","year":"2020","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215044_bb0060","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41417-023-00659-2","article-title":"Targeting SOD1 via RNAi with PEGylated graphene oxide nanoparticles in platinum-resistant ovarian cancer","volume":"30","author":"Sz\u00e9n\u00e1si","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12951-021-00874-9","article-title":"Graphene oxide (GO)-based nanosheets with combined chemo\/photothermal\/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP)","volume":"19","author":"Guo","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12989-016-0168-y","article-title":"Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms","volume":"13","author":"Ou","year":"2016","journal-title":"Part. Fibre Toxicol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0075","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1038\/s41598-018-29019-z","article-title":"Long-term in vivo biodistribution and toxicity study of functionalized near-infrared persistent luminescence nanoparticles","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215044_bb0080","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1021\/acsnano.6b00539","article-title":"Improved in vitro and in vivo biocompatibility of graphene oxide through surface modification: poly(acrylic acid)-functionalization is superior to PEGylation","volume":"10","author":"Xu","year":"2016","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215044_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121850","article-title":"CD44: a multifunctional mediator of Cancer progression","volume":"11","author":"Hassn Mesrati","year":"2021","journal-title":"Biomolecules"},{"issue":"24","key":"10.1016\/j.bioadv.2026.215044_bb0090","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","article-title":"Hyaluronan-CD44 interactions in Cancer: paradoxes and possibilities","volume":"15","author":"Toole","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s11671-022-03706-3","article-title":"Gold Nanorods-based Photothermal therapy: interactions between biostructure, nanomaterial, and near-infrared irradiation","volume":"17","author":"Zhou","year":"2022","journal-title":"Nanoscale Res. Lett."},{"issue":"16","key":"10.1016\/j.bioadv.2026.215044_bb0100","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1039\/D5BM00670H","article-title":"Indocyanine green-based nanomedicine for theranostic applications","volume":"13","author":"Li","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioadv.2026.215044_bb0105","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.2147\/IJN.S179046","article-title":"pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-trans-retinoic acid and paclitaxel for cancer combination chemotherapy","volume":"13","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0110","first-page":"65","article-title":"TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer","volume":"12","author":"Matthaiou","year":"2022","journal-title":"Bioimpacts"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215044_bb0115","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/jbm.a.36770","article-title":"Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use","volume":"107","author":"Aquib","year":"2019","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215044_bb0120","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer (review)","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215044_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126702","article-title":"ROS and miRNA dysregulation in ovarian cancer development, angiogenesis and therapeutic resistance","volume":"23","author":"Stieg","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.bioadv.2026.215044_bb0130","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1039\/D4NR00243A","article-title":"External stimuli-triggered photodynamic and sonodynamic therapies in combination with hybrid nanomicelles of ICG@PEP@HA: laser vs. ultrasound","volume":"16","author":"Kong","year":"2024","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.bioadv.2026.215044_bb0135","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.cell.2021.04.027","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell"},{"issue":"37","key":"10.1016\/j.bioadv.2026.215044_bb0140","article-title":"Mortalin and PINK1\/Parkin-mediated Mitophagy represent ovarian Cancer-selective targets for drug development","volume":"12","author":"Chandra","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.168043","article-title":"SREBP1a induced PINK1-Parkin mediated mitophagy facilitates ovarian cancer progression","volume":"1872","author":"Tanbir","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215044_bb0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41565-019-0392-3","article-title":"Miniature gold nanorods for photoacoustic molecular imaging in the second near-infrared optical window","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0885328217712110","article-title":"Hyaluronic acid and Arg-Gly-asp peptide modified graphene oxide with dual receptor-targeting function for cancer therapy","volume":"32","author":"Guo","year":"2017","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.bioadv.2026.215044_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.carbon.2012.08.051","article-title":"Fabrication of a graphene oxide\u2013gold nanorod hybrid material by electrostatic self-assembly for surface-enhanced Raman scattering","volume":"51","author":"Hu","year":"2013","journal-title":"Carbon"},{"key":"10.1016\/j.bioadv.2026.215044_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118810","article-title":"Hydrazided hyaluronan\/cisplatin\/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer","volume":"276","author":"Hou","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2026.215044_bb0170","article-title":"Antibacterial activity of bismuth oxide nanoparticles compared to amikacin against Acinetobacter baumannii and Staphylococcus aureus","volume":"1","author":"Jawad","year":"2022","journal-title":"J. Nanomater."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215044_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2023.101696","article-title":"Influence of Cu2+ substitution on the structural, optical, magnetic, and antibacterial behaviour of zinc ferrite nanoparticles","volume":"27","author":"Nadhiya","year":"2023","journal-title":"J. Saudi Chem. Soc."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215044_bb0180","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1021\/acsnano.5c20971","article-title":"Dynamic light scattering method using derived count rate to accurately quantify lipid nanoparticle concentrationa double-blind study","volume":"20","author":"Nandrajog","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2026.215044_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9863616","article-title":"Copper oxide nanoparticle-decorated carbon nanoparticle composite colloidal preparation through laser ablation for antimicrobial and antiproliferative actions against breast cancer cell line, MCF-7","volume":"2022","author":"Mohammed","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215044_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/met13040735","article-title":"Au\/ZnO nanocomposites prepared by laser ablation for enhancement of antibacterial activity and cytotoxic properties against cancer cells","volume":"13","author":"Alhujaily","year":"2023","journal-title":"Metals"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0195","article-title":"Unveiling the nature of Pt-induced anti-deactivation of Ru for alkaline hydrogen oxidation reaction","volume":"15","author":"Fang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2026.215044_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.122156","article-title":"Adsorption kinetic models: physical meanings, applications, and solving methods","volume":"390","author":"Wang","year":"2020","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.bioadv.2026.215044_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2022.117104","article-title":"A critical review of adsorption isotherm models for aqueous contaminants: curve characteristics, site energy distribution and common controversies","volume":"329","author":"Hu","year":"2023","journal-title":"J. Environ. Manag."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215044_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080386","article-title":"Physico-chemical and biological evaluation of PLCL\/SF nanofibers loaded with oregano essential oil","volume":"11","author":"Khan","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.215044_bb0215","article-title":"Mitochondria-enriched nanovesicles: a novel approach for treating radiation-induced skin injury","volume":"35","author":"Zhu","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215044_bb0220","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/fft2.44","article-title":"Guidelines for cell viability assays","volume":"1","author":"Kamiloglu","year":"2020","journal-title":"Food Frontiers"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215044_bb0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/laban.254","article-title":"Estimation of rat mammary tumor volume using caliper and ultrasonography measurements","volume":"42","author":"Faustino-Rocha","year":"2013","journal-title":"Lab Anim (NY)"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215044_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062989","article-title":"Functionalized reduced graphene oxide as a versatile tool for cancer therapy","volume":"22","author":"Dash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2026.215044_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-031-58311-7_4","article-title":"Drug-resistant epithelial ovarian Cancer: current and future perspectives","volume":"1452","author":"Mehrotra","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"13","key":"10.1016\/j.bioadv.2026.215044_bb0240","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioadv.2026.215044_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/11795549231187264","article-title":"Mirvetuximab soravtansine in platinum-resistant ovarian cancer","volume":"17","author":"Gonzalez-Ochoa","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215044_bb0250","article-title":"A nanocomposite competent to overcome cascade drug resistance in ovarian cancer via mitochondria dysfunction and NO gas synergistic therapy","volume":"18","author":"Zhong","year":"2023","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.bioadv.2026.215044_bb0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","article-title":"Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments","volume":"77","author":"Marchetti","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-025-00620-z","article-title":"Suppression of CYLD by HER3 confers ovarian cancer platinum resistance via inhibiting apoptosis and by inducing drug efflux","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215044_bb0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10142-023-01075-3","article-title":"SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer","volume":"23","author":"Zheng","year":"2023","journal-title":"Funct. Integr. Genomics"},{"issue":"32","key":"10.1016\/j.bioadv.2026.215044_bb0270","doi-asserted-by":"crossref","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","article-title":"Mitochondria-targeted multifunctional Nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung Cancer","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3892\/ol.2024.14782","article-title":"Efficacy and safety of different angiogenesis inhibitors combined with PARP inhibitors in the treatment of ovarian cancer: a systematic review and meta-analysis","volume":"29","author":"Huang","year":"2025","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215044_bb0280","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-21-3023","article-title":"Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian Cancer: phase III trial (L-MOCA)","volume":"28","author":"Gao","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"31","key":"10.1016\/j.bioadv.2026.215044_bb0285","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1039\/D4NR01417K","article-title":"Advances in biomimetic AIE nanoparticles for diagnosis and phototherapy","volume":"16","author":"Chau","year":"2024","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215044_bb0290","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/acsabm.2c01000","article-title":"Multifunctional carbon-based nanoparticles: Theranostic applications in Cancer therapy and diagnosis","volume":"6","author":"Hosseini","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215044_bb0295","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/1061186X.2021.1886301","article-title":"Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects","volume":"29","author":"Sajjadi","year":"2021","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215044_bb0300","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/acs.biomac.5c00692","article-title":"Thermoresponsive hyaluronate-based Nanogels for enhanced Phenanthriplatin delivery in cisplatin-resistant ovarian Cancer","volume":"26","author":"Late\u010dka","year":"2025","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215044_bb0305","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jemt.23213","article-title":"Detoxification and functionalization of gold nanorods with organic polymers and their applications in cancer photothermal therapy","volume":"82","author":"Jin","year":"2019","journal-title":"Microsc. Res. Tech."},{"issue":"26","key":"10.1016\/j.bioadv.2026.215044_bb0310","doi-asserted-by":"crossref","first-page":"32945","DOI":"10.1021\/acsami.4c01078","article-title":"Development of Indocyanine green\/methyl-\u03b2-cyclodextrin complex-loaded liposomes for enhanced Photothermal Cancer therapy","volume":"16","author":"Kim","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"17","key":"10.1016\/j.bioadv.2026.215044_bb0315","doi-asserted-by":"crossref","first-page":"15186","DOI":"10.1021\/acsomega.2c01306","article-title":"Anisotropic Plasmonic gold Nanorod-Indocyanine green@reduced graphene oxide-doxorubicin Nanohybrids for image-guided enhanced tumor Theranostics","volume":"7","author":"Maji","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioadv.2026.215044_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103603","article-title":"Co-delivery of Bcl-2 siRNA and doxorubicin through gold nanoparticle-based delivery system for a combined cancer therapy approach","volume":"74","author":"Tun\u00e7","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.bioadv.2026.215044_bb0330","article-title":"ROS-induced DCTPP1 upregulation contributes to cisplatin resistance in ovarian cancer","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"45","key":"10.1016\/j.bioadv.2026.215044_bb0335","doi-asserted-by":"crossref","first-page":"74132","DOI":"10.18632\/oncotarget.12356","article-title":"Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2\u03b1-ATF4-xCT pathway","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioadv.2026.215044_bb0340","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","article-title":"Reactive oxygen species and mitochondria: a nexus of cellular homeostasis","volume":"6","author":"Dan Dunn","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioadv.2026.215044_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111075","article-title":"Drp1-mediated mitochondrial fission promotes pulmonary fibrosis progression through the regulation of lipid metabolic reprogramming by ROS\/HIF-1\u03b1","volume":"117","author":"Tong","year":"2024","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215044_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bcpt.14034","article-title":"Aflatoxin B1 induces ROS-dependent mitophagy by modulating the PINK1\/Parkin pathway in HepG2 cells","volume":"135","author":"Wang","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioadv.2026.215044_bb0355","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2025.01.004","article-title":"Molecular regulation of mitophagy signaling in tumor microenvironment and its targeting for cancer therapy","volume":"85","author":"Behera","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215044_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101270","article-title":"Mitophagy in cell death regulation: insights into mechanisms and disease implications","volume":"14","author":"Lin","year":"2024","journal-title":"Biomolecules"},{"issue":"46","key":"10.1016\/j.bioadv.2026.215044_bb0365","doi-asserted-by":"crossref","first-page":"eadx7809","DOI":"10.1126\/sciadv.adx7809","article-title":"The tumor suppressor LACTB remodels mitochondria to promote cytochrome c release and apoptosis","volume":"11","author":"Kamerkar","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215044_bb0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/hsz-2020-0231","article-title":"Kill one or kill the many: interplay between mitophagy and apoptosis","volume":"402","author":"Wanderoy","year":"2020","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bioadv.2026.215044_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157333","article-title":"Prosapogenin CP4 exacerbates mitophagy to induce apoptosis via AMPK-mTOR and PINK1\/Parkin pathways in A549 cells","volume":"148","author":"Pan","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T21:29:49Z","timestamp":1786051789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":73,"alternative-id":["S2772950826003420"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215044","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multifunctional graphene oxide-based nanoplatform sensitizes ovarian cancer to cisplatin via ROS-PINK1\/Parkin mitophagy under chemo-photothermal-photodynamic synergy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215044"}}